The company is also raising its full-year guidance to $14.9 billion in adjusted EBITDA, an 8.8% increase from its last ...

As US President-elect Donald Trump reaches for his tariff hike sword, countries may soon be engaged in an unavoidable trade ...

Target or technology pipeline and corporate benchmark analysis and assessment reports can be prepared according to the specifications of the client from the pharmaceutical ... global health ...

Nimish Shah, Partner at Venrock, added, “With an impressive management team, industry-leading peptide engineering capabilities, scaled manufacturing ... to bind simultaneously to albumin and to a drug ...